Market Cap | 117.56M | P/E | - | EPS this Y | 83.30% | Ern Qtrly Grth | - |
Income | -6.48M | Forward P/E | - | EPS next Y | 4.00% | 50D Avg Chg | -2.00% |
Sales | 2.9M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -48.00% |
Dividend | N/A | Price/Book | 10.13 | EPS next 5Y | - | 52W High Chg | -93.00% |
Recommedations | 2.00 | Quick Ratio | 0.37 | Shares Outstanding | 37.56M | 52W Low Chg | 20.00% |
Insider Own | 80.28% | ROA | -26.75% | Shares Float | 14.77M | Beta | -0.47 |
Inst Own | 0.03% | ROE | -69.76% | Shares Shorted/Prior | 7.96K/14.19K | Price | 3.13 |
Gross Margin | 10.67% | Profit Margin | -223.70% | Avg. Volume | 14,533 | Target Price | 6.00 |
Oper. Margin | -711.20% | Earnings Date | - | Volume | 1,331 | Change | -1.26% |
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Maxim Group | Buy | Jan 30, 24 |